Medicure (MCUJF) Interest & Investment Income (2009 - 2025)
Medicure's (MCUJF) quarterly Interest & Investment Income came in at -$14434.2 in Q2 2025, up 45.16% year-on-year from -$9943.6 in Q2 2024, and up 39.08% quarter-over-quarter from -$23695.2 in Q1 2025.
Medicure (MCUJF) Interest & Investment Income (2009 - 2025) Analysis & Trends
Medicure's Interest & Investment Income history runs 6 years deep, the most recent figure standing at -$14434.2 for Q2 2025.
- On a quarterly basis, Interest & Investment Income rose 45.16% year-over-year to -$14434.2 in Q2 2025; TTM through Jun 2025 was -$94275.3, a 182.66% decrease from a year earlier, with the FY2025 full-year figure at -$87318.0, up 27.55% from the prior year.
- Interest & Investment Income grew to -$14434.2 in Q2 2025 per MCUJF's latest filing, from -$23695.2 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $33054.1 in Q4 2023 and bottomed at -$42950.9 in Q4 2024.
- The 3-year median for Interest & Investment Income is -$19064.7 (2025), against an average of -$15953.5.
- Across the five-year window, Interest & Investment Income plunged 489.64% in 2024 and surged 45.16% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $33054.1 in 2023, then plunged by 229.94% to -$42950.9 in 2024, then soared by 66.39% to -$14434.2 in 2025.
- Per Business Quant, the three latest MCUJF Interest & Investment Income figures stand at -$14434.2 (Q2 2025), -$23695.2 (Q1 2025), and -$42950.9 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -14,434.25 |
| Mar 31, 2025 | -23,695.16 |
| Dec 31, 2024 | -42,950.95 |
| Sep 30, 2024 | -13,194.96 |
| Jun 30, 2024 | -26,321.06 |
| Mar 31, 2024 | -37,847.77 |
| Dec 31, 2023 | 33,054.10 |
| Sep 30, 2023 | -2,237.79 |
| May 31, 2011 | -823.62 |
| Feb 28, 2011 | -146.29 |
| Nov 30, 2010 | 3,911.14 |
| Aug 31, 2010 | 961.34 |
| May 31, 2010 | 7,824.10 |
| Feb 28, 2010 | 15.22 |
| Nov 30, 2009 | 3,953.97 |
| Aug 31, 2009 | 1,438.65 |
| May 31, 2009 | 8.00 Mn |
| Feb 28, 2009 | 29.00 Mn |